|
|
||||||||
Department of Microbiology and Immunology, Shimane Medical University, Izumo, Shimane, Japan
Murine B-1 cells are thought to develop from Ig-
progenitors early in ontogeny and to expand by self-renewal. To examine
the early development of Ig+ precursors of B-1 cells for
bromelain-treated mouse RBC, the transient presence of RidA, a rat
anti-Id mAb for VH11/V
9-type
anti-bromelain-treated mouse Abs, was produced in neonatal mice.
The presence of RidA during days 0 to 10 of age resulted in an 80%
reduction in peritoneal RidA-Id+ B cells and B cells
secreting RidA-Id+ Ig after LPS stimulation in 8-wk-old
mice. This suggests that most Ig+ precursors for adult
RidA-Id+ B cells already exist in 10-d-old mice. However,
RidA injected into mice on day 10 had to persist for >4 days to result
in a significant reduction in adult B cells. Similarly, although RidA
injected into adult mice bound immediately to membrane Ig (mIg) of the
peritoneal RidA-Id+ B cells, a RidA persistence for >4
days was required to suppress LPS reactivity of peritoneal and splenic
B cells. The binding of RidA to mIg preexisting on B cells has no
apparent effect on the ability of neonatal B cells to expand clonally
or on the ability of adult B cells to secrete RidA-Id+ Ig
after LPS stimulation. Both abilities evidently are suppressed by the
accumulation of reaction between freshly expressed mIg and RidA.
This article has been cited by other articles:
![]() |
K. Balabanian, J. Couderc, L. Bouchet-Delbos, A. Amara, D. Berrebi, A. Foussat, F. Baleux, A. Portier, I. Durand-Gasselin, R. L. Coffman, et al. Role of the Chemokine Stromal Cell-Derived Factor 1 in Autoantibody Production and Nephritis in Murine Lupus J. Immunol., March 15, 2003; 170(6): 3392 - 3400. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Chumley, J. M. Dal Porto, S. Kawaguchi, J. C. Cambier, D. Nemazee, and R. R. Hardy2 A VH11V{kappa}9 B Cell Antigen Receptor Drives Generation of CD5+ B Cells Both In Vivo and In Vitro J. Immunol., May 1, 2000; 164(9): 4586 - 4593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |